Arterial hypertension is one of most common diseases in the world with variable etiologies, yet the exact cause cannot always be found. It is classified as essential (primary) or secondary hypertension. Unlike secondary hypertension, primary hypertension has no known cause. Animal models have been used to investigate the pathophysiology of the disease and for testing new treatment strategies. Using animal models to better understand the etiology, prevention, and treatment of hypertension depends on their accuracy for representing human disease. Current challenges in this field include the development of models mimicking the common hypertensive syndromes and the development of new prevention and treatment strategies. Animal models may be beneficial to address these challenges. While choosing the appropriate model of hypertension, scientists need to choose between small and large animal models. The research scope and objectives, experimental expenses, animal welfare, and practical suitability should all be considered. The advantages and disadvantages of these models need to be assessed in detail in order to select the best model. From the many models of arterial hypertension, it can be distinguish different models of essential and secondary arterial hypertension. Of the essential arterial hypertension three main methods are noteworthy, pharmacological, environmental conditions, and genetic model. As for secondary hypertension, it can be challenged by physical methods such as renal artery clipping or its microembolization.
Download full-text PDF |
Source |
---|
Mayo Clin Proc
December 2024
Division of Nephrology, Department of Medicine, at the David Geffen School of Medicine at University of California, Los Angeles, CA, USA.
Current clinical practice guidelines were established by several organizations to guide the diagnosis and treatment of hypertension in men and women in a similar manner despite data demonstrating differences in underlying mechanisms. Few publications have provided a contemporary and comprehensive review focused on characteristics of hypertension that are unique to women across their life spectrum. We performed a computerized search using PubMed, OVID, EMBASE, and Cochrane library databases between 1995 and 2023 that highlighted relevant clinical studies, challenges to the management of hypertension in women, and multidisciplinary approaches to hypertension control in women, including issues unique to racial and ethnic minority groups.
View Article and Find Full Text PDFCJC Open
December 2024
Department of Cardiology, Keio Hospital, Tokyo, Japan.
Front Cardiovasc Med
December 2024
Department of Cardiology, The Fifth Affiliated Hospital of Wenzhou Medical University, Lishui Central Hospital, Zhejiang, China.
Background: The association between healthy lifestyle and American Heart Association (AHA) Life's Essential 8 (LE8) score and apparent treatment-resistant hypertension(aTRH)remains uncertain. We aimed to explore the association between healthy lifestyle and higher LE8 score and apparent treatment-resistant hypertension in the general population.
Methods: Using NHANES data from 2005 to 2018, we included and analyzed information on 7,474 participants eligible for this study.
Vasc Health Risk Manag
December 2024
Department of Emergency Medical Service, Faculty of Nursing and Midwifery, Wroclaw Medical University, Wroclaw, Poland.
Background And Purpose: Body mass index (BMI), as a straightforward measure, is widely used in clinical practice, and its results are linked to HT and patient prognosis. This study aimed to ascertain if sex differences exist in the prognostic significance of BMI at the time of admission to the cardiology unit, and how this impacts the LOHS for patients suffering from hypertension.
Patients And Methods: A retrospective analysis of the medical records of 486 patients admitted urgently with a diagnosis of HT to the Cardiology Department at University Hospital in Wroclaw (Poland) between January 2017 and June 2021 was conducted.
Front Med (Lausanne)
December 2024
Department of Cardiology, The University-Town Hospital of Chongqing Medical University, Chongqing, China.
Purpose: To systematically evaluate the clinical efficacy and safety of targeted drugs in patients with pulmonary arterial hypertension (PAH) with cardiac function grades III-IV, and conduct a meta-analysis.
Methods: Two researchers independently searched the PubMed, EMBASE, and Cochrane Library databases for relevant studies, with the search period extending from the establishment of the databases to March 2024. Meta-analysis was performed using statistical software Review Manager 5.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!